本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。
Skip to main content
Contact Us
FONT SIZE
normal
large
LANGUAGE
JP
EN
HOME
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
Corporate Message
Digital Transformation
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Pipeline and Intellectual Property
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
Stock Information
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
How to Use the IR Site
Sustainability
Our Sustainability
Environmental
Social
Governance
ESG Chart and ESG Data Book
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Sustainability News
Various Contrasting Tables
Policies
Integrated Report
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Site Policy
Cookie Policy
SNS コミュニティ・ガイドライン
公式Webサイト・SNS
Sitemap
About ASKA Pharmaceutical Holdings
Company Overview
Group Companies
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
Corporate Message
Digital Transformation
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
Top Message
Medium-Term Management Plan
ASKA Pharmaceutical Holdings at a glance
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Pipeline and Intellectual Property
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
Stock Information
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
How to Use the IR Site
Sustainability
Integrated Report
Our Basic Policy for Sustainability
Various Contrasting Tables
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Initiatives for Sustainability and SDGs
Importance of Female Healthcare and Social Issues
Disclosures based on TCFD recommendations
Environmental
Governance
External Evaluation
Third-party Opinion
Various Contrasting Tables
Integrated Report
Social
ESG Chart and ESG Data Book
Initiatives and Member Organizations
Sustainability News
Policies
HOME
>
HOME
>
For Our Shareholders and Investors
>
ASKA Pharmaceutical Holdings at a glance
>
Medicine & Body Glossary
Medicine & Body Glossary
PRINT
Thyroid gland
The thyroid gland produces thyroid hormones that stimulate metabolism and growth. The thyroid gland is located just below the throat and looks like a butterfly with its wings spread. It is an organ weighing about 10 to 20 grams.
Uterus
The uterus is the organ that nurtures a fertilized egg and plays a central role in pregnancy.
Ovary
The ovaries produce estrogen and progesterone, two female hormones involved in the development of a feminine body, pregnancy, and childbirth.
Hormones
Hormones are important substances that regulate various functions of the body in order to maintain organs and tissues in a stable state. Growth of bones and muscles, energy metabolism, blood pressure, appetite, and digestion of food are also influenced by hormones. Hormones are produced in the brain and various organs, and more than 100 types of hormones have been discovered.
Female Hormone
Hormones produced in the ovaries of women. There are two types of female hormones: estrogen and progesterone.
Estrogen plays the role of “preparing for pregnancy” and “building a feminine body,” while progesterone plays the role of “maintaining pregnancy.
Estrogen
Hormone that thickens the endometrium and prepares the body for pregnancy. It helps build a womanly body (breast development and a rounded body). It also stimulates the production of collagen and maintains healthy blood vessels, bones, joints, and brain.
Progesterone
Progesterone is a hormone that makes it easier to conceive by maintaining the endometrium, which has become thickened through the action of estrogen, soft. It stores water and nutrients, and once pregnancy is established, it maintains the pregnancy. It also raises body temperature and increases appetite.
Menstruation
A phenomenon that occurs when the endometrium is shed, resulting in bleeding. Estrogen and progesterone are involved.
Dysmenorrhea
A condition in which menstruation is accompanied by symptoms such as lower abdominal pain and back pain that interfere with daily life and improve with the end of menstruation. Dysmenorrhea can be divided into two types: functional dysmenorrhea, in which symptoms appear without a causative disease, and organic dysmenorrhea, which is caused by a uterine disease.
LEP (low-dose estrogen/progestin combination) formulation
One of the drugs used in the treatment of dysmenorrhea. They reduce menstrual pain by resting ovulation and preventing the endometrium from thickening.
PMS (Premenstrual Syndrome)
Various physical and mental discomforts that begin a few days (3 to 10 days) before menstruation and subside with the onset of menstruation. When the mental symptoms are particularly severe and interfere with daily life, it may be diagnosed as “Premenstrual Dysphoric Disorder (PMDD).
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Group Companies
Business Activities
Corporate History
Organization Chart
Corporate Message
Digital Transformation
ASKA Pharmaceutical Holdings in Numbers
Policies
Access Map
For Our Shareholders and Investors
IR News
IR Library
IR Library
Financial Results
Annual Securities Report
Integrated Report
Fact Sheet
IR Calendar
Management Strategies and Policies
Management Strategies and Policies
Top Message
Medium-Term Management Plan
Business Risks
Disclosure Policy
Governance
Governance
Basic Principles / Corporate Governance Structure
Corporate Governance Basic Policy
Corporate Governance Report (Japanese version only)
Board Members
Compliance / Risk Management
Internal Control System
Dialogue with Shareholders
Roundtable Discussion with Outside Directors
Material Issues: G
ESG Chart and ESG Data Book
Pipeline and Intellectual Property
Financial Highlights
Financial Highlights
Performance Review
Performance Highlights
Financial Conditions
Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Cash Flows
Earnings Forecast
Non-Financial Highlights (ESG Chart and ESG Data Book)
ASKA Pharmaceutical Holdings at a glance
ASKA Pharmaceutical Holdings at a glance
Point1 About ASKA - Understanding & History -
Point2 About ASKA - Our Strengths -
Point3 Highly Specialized Product Lineup
Point4 Continuously Evolving R&D
Point5 Stable Shareholder Returns
Business Model
Frequently Asked Questions
Medicine & Body Glossary
Stock Information
Stock Information
Stock summary information
Shareholder Information
Shareholders' Meeting
Stock Price Information
Dividends and Dividend Payout Ratio
Articles of Incorporation and Stock Handling Regulations
Analyst Coverage
Shareholder Newsletters (Japanese version only)
Disclaimer
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
How to Use the IR Site
Sustainability
Our Sustainability
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Initiatives for Sustainability and SDGs
Importance of Female Healthcare and Social Issues
Disclosures based on TCFD recommendations
Environmental
Environmental
Environmental Management
Material Issues: E
Disclosures Based on TCFD Recommendations
Decarbonization Initiatives
Initiatives for Water Resource
Initiatives for Recycle-Oriented Society and Biodiversity
ESG Chart and ESG Data Book
Social
Social
Stakeholder Outcomes/Impact
Respect for Human Rights
Labour Practices
Diversity & Inclusion
Initiatives to Promote the Advancement of Women
Health Management Initiatives
Fair Operating Practices
Supply Chain
Customer Health and Safety
Social Contribution Activities(Community Involvement and Development)
Material Issues: S
ESG Chart and ESG Data Book
Governance
ESG Chart and ESG Data Book
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Sustainability News
Various Contrasting Tables
Policies
Integrated Report
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Site Policy
Cookie Policy
SNS コミュニティ・ガイドライン
公式Webサイト・SNS
Sitemap
TOP